Surrozen Inc.

Last updated September 27, 2026

Organization details

Legal name
Surrozen Inc.
Former names
Consonance-HFW Acquisition Corp.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
South SAN Francisco
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SRZN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001824893
EIN
30-1374889

Board of directors

Chief executives

Craig C. Parker · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of Surrozen Inc.'s board connections CalciMedica Inc. CalciMedica Inc. Cerus Corporation Cerus Corporation Cue Biopharma Inc. Cue Biopharma Inc. Metagenomi Therapeutics Inc. Metagenomi Therapeutic... Tango Therapeutics Inc. Tango Therapeutics Inc... Eric Bjerkholt Eric Bjerkholt Mace Rothenberg Mace Rothenberg Shao-Lee Lin Shao-Lee Lin Surrozen Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$16,849,701
56 purchases by 6 insiders
Sold, last 12 months
$7,231,021
7 sales by 4 insiders
Date Insider Transaction Shares Price Value
Oct 20, 2026 COLUMN GROUP III GP, LP 10% owner In-the-money exercise +485,830 $11.60 $5,635,628
Oct 20, 2026 Tim Kutzkey Director, 10% owner In-the-money exercise +485,830 $11.60 $5,635,628
Oct 20, 2026 COLUMN GROUP III GP, LP 10% owner In-the-money exercise +548,653 $11.60 $6,364,375
Oct 20, 2026 Tim Kutzkey Director, 10% owner In-the-money exercise +548,653 $11.60 $6,364,375
Oct 20, 2026 COLUMN GROUP III GP, LP 10% owner In-the-money exercise +517,241 $11.60 $5,999,996
Oct 20, 2026 Tim Kutzkey Director, 10% owner In-the-money exercise +517,241 $11.60 $5,999,996
Jul 22, 2026 Yu Chen-Ming 10% owner Open-market sale −162,500 $21.25 $3,453,125
Jul 22, 2026 Yu Chen-Ming 10% owner Open-market sale −162,500 $21.25 $3,453,125
Jun 15, 2026 Maleki Andrew Pedrum Officer (Chief Financial Officer) Grant or award +607 $19.01 $11,539
Jun 15, 2026 Li Yang Officer (Exec. Vice President, Research) Grant or award +1,666 $8.11 $13,511
Jun 15, 2026 Williams Charles O Officer (Chief Operating Officer) Grant or award +1,666 $8.11 $13,511
Jun 15, 2026 Craig C. Parker Director, Officer (Chief Executive Officer) Grant or award +1,622 $8.11 $13,154
May 4, 2026 Li Yang Officer (Exec. Vice President, Research) Open-market sale −1,584 $33.33 $52,795
May 4, 2026 Williams Charles O Officer (Chief Operating Officer) Open-market sale −2,036 $33.33 $67,860
May 4, 2026 Craig C. Parker Director, Officer (Chief Executive Officer) Open-market sale −4,524 $33.33 $150,785

Organizations in the same sector, closest in location and size first.

Questions about Surrozen Inc.

Who is the CEO of Surrozen Inc.?

Craig C. Parker is Surrozen Inc.'s Chief Executive Officer.

How many directors are on Surrozen Inc.'s board?

Surrozen Inc.'s board has 9 directors: Anna Berkenblit, Christopher Y. Chai, Craig C. Parker, David J. Woodhouse, Eric Bjerkholt, Mace Rothenberg, Mary Haak-Frendscho, Shao-Lee Lin and Tim Kutzkey.

Are Surrozen Inc. insiders buying or selling shares?

Over the last 12 months, Surrozen Inc. insiders bought $16.8 million of shares in 56 purchases and sold $7.2 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="surrozen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.